“We couldn’t have asked our advisory board for 2 larger charges than Mr. Swarts and Dr. Harder,” said Marco Hegyi, CEO of GrowLife. “Looking at their rich past, they revel in global elegance in upcoming hemp operations, allowing us to better serve the home chain and adorn the non-easy conditions faced by hemp producers, along with a systematic attitude in which the cannabis space is counted. We pride ourselves on painting with the best, now uploading those two experts to our advisory committee elevates GrowLife’s position as true leaders in cloning to reject innovation. We continue to see a strong demand for JStomer CBD products and providing the raw curtain infrastructure had to meet this call, it is exactly where GrowLife will continue to capitalize”.
Mr. Swarts is a veteran of the cannabis industry, who has held leadership positions in the world’s largest cannabis and agriculture corporations for more than a decade. He revels in managing the operational power of cannabis and hemp organizations on a large scale. This joy adds a bountiful burden to GrowLife’s CBD-rich hemp clone operation. Mr. Swarts’ most important titles come with the general manager and vice president of operations at the cannabis and hemp production facilities, and he recently held a checkpoint at one of the largest and most popular built-in hemp brands in the United States. Mr. Swarts joins the Advisory Board with love and unre prestige in view of the prospect of CBD-rich hemp and could focus on streamlining and expanding this component of GrowLife’s business.
Dr. Harder is a phytologist who has committed his career to apple genomics and agriculture. A graduate of the University of California, Berkeley, Dr. Harder has held several professional, legislative and board positions in prestigious foundations, gardens, and educational organizations in the field of plant science. It is a multi-editing editor on the topics of botabig apple and the identity and verification of plant species and environmental considerations. As a member of the Advisory Board, Dr. Harder will paint with GrowLife team members to expand their wisdom in plant genetics and strive to improve the quality of GrowLife hemp clone products.
“As a lifelong plant researcher, I seek to help the GrowLife team deepen their genetic expertise in plant production,” Added Dr. Daniel Harder. “I have helped countless farmers perceive their crops, their region and the intellectual conditions of the environment, and I hope to pass this low pressure directly to the GrowLife team so that their consumers can grow more h8 CBD-rich hemp functionalities by using the company’s homeowners initiator
About GrowLife, Inc.
GrowLife, Inc. (PHOT) aims to become the country’s largest crop merchant to produce organic products, green herbs and vegetables and herbal medicines. Our task is to contribute directly to the wise song of our customers. Through a network of local representatives covering Canada, regional centers and its e-commerce team, GrowLife offers a range of essential services and services, as well as environments, hydroponic crops and next-generation soils, plant nutrients and thousands of other products. specialized crops. . GrowLife is headquartered in Kirkland, Washington and was founded in 2012.
Public Relations Contact:
Investor Relations Contact: [email protected]
PROSPECTIVE STATEMENT:
This press release includes statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in various places in this release and come with all statements that do not appear as statements of recent facts about the intent, trust or expectations of GrowLife, Inc., its administrators or officials with respect to, among other things: (i) financing plans; (ii) trends affecting your economic position or trading result; (iii) expansion strategy and operational strategy. Words can, would, wait, estimate, can, believe, forward expressions and the like, and their adaptations are intended to detect forward search statements. Investors are cautioned that such forward-looking statements do not look like promises of long-term functionality and involve dangers and uncertainties, whose big apple is beyond growLife, Inc.’s controllability, and the genuine effects may differ from the most important friends. projects in the long run. forward statements due to a wide variety of factors.